Healthcare company Baxter International (NYSE:BAX) reported in Q1 CY2026, with sales up 2.9% year on year to $2.70 billion.

Baxter International Inc. BAX reported better-than-expected first-quarter earnings on Thursday and reaffirmed its fiscal 2026 ...

Baxter’s latest quarterly performance highlights steady healthcare demand, evolving strategy, and its positioning within the ...

Baxter stock gains attention after strong sales performance. Explore key drivers, healthcare trends, and factors shaping ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Despite beating revenue estimates, Baxter International’s ...